Latest News

Amid a sea of mergers and acquisitions, EnvisionRxOptions continues to offer plan sponsors a valuable alternative

Earlier this month, Rite Aid Corporation and Albertsons Companies announced a mutual decision to terminate their previously publicized merger agreement. While the merger would have presented some benefits to EnvisionRxOptions, a wholly owned subsidiary of Rite Aid, we remain optimistic on the continued growth of our companies. The media has been very favorable of the value of EnvisionRxOptions, and more and more plan sponsors and patients are adopting our visibly different approach.

Evaluating Governance Changes in Consultation with Stockholders

Schedules Annual Meeting of Stockholders

PRESS RELEASE (Aug 08, 2018): Rite Aid Corporation (NYSE: RAD) today announced that it has mutually agreed with Albertsons Companies Inc. ("Albertsons") to terminate their previously announced merger agreement.

Pharmacy benefit manager’s enhanced program helps payers safely address members' pain and lower risk of abuse.

Program helps educate and guide patients prescribed opioids to safely use these powerful drugs.

PRESS RELEASE: In response to the nation’s opioid epidemic, pharmacy benefit manager, EnvisionRx, a division of EnvisionRxOptions, announced enhancements to its comprehensive opioid and pain management program, EnvisionCare Pain Management. Available immediately, the program includes pre-emptive prescription strategies, such as limiting first-time fills to seven days*, prior authorizations on certain medications, and shortened windows to refill prescriptions. This comprehensive program aligns with the healthcare company’s overall pain management strategy, as well as the guidelines set by the Centers for Disease Control and Prevention (CDC).

PRESS RELEASE – EnvisionRxOptions, a subsidiary of Rite Aid, has joined the 41^st Rite Aid Cleveland Marathon as the Presenting Sponsor for the 5K and 8K races being run on Saturday, May 19.

EnvisionRxOptions is a national pharmacy services and healthcare company headquartered in greater Cleveland. With most of its 1,500+ employees located in the Cleveland area, EnvisionRxOptions will join the many sponsors and supporters of the 41^st annual race weekend.

Kansas City Business Journal Recognizes Pharmacy Benefit Manager for Financial Performance, Innovation and Community Involvement

PRESS RELEASE: MedTrakRx, a pharmacy benefit manager (PBM) and a division of EnvisionRxOptions (a wholly owned subsidiary of Rite Aid), was recently selected by the Kansas City Business Journal as a 2018 Champion of Business award winner. The award recognizes area businesses that excel in financial performance, innovation and community involvement. This is the second time MedTrakRx has been honored with this prestigious award, which they will receive along with other recipients during the 12^th annual awards luncheon on May 4 at the Intercontinental Hotel in Kansas City.

Pharmacy Compounding Accreditation Board (PCAB) Recognizes EnvisionPharmacies for Operational and Clinical Excellence in the Creation of Customized Medications

PRESS RELEASE: EnvisionPharmacies, a division of EnvisionRxOptions, announced that its compounding pharmacy received accreditation from the Pharmacy Compounding Accreditation Board (PCAB), a service of Accreditation Commission for Health Care (ACHC). This accreditation demonstrates commitment to the highest industry standards for quality and safety. EnvisionPharmacies also holds accreditation for both Mail and Specialty Pharmacy from URAC, a healthcare management accrediting organization.

PRESS RELEASE: We are excited to share some important news that will make EnvisionRxOptions part of a leading food, health and wellness company with expanded capabilities to better serve our patients and clients. This morning, Rite Aid and Albertsons Companies, one of the nation’s largest grocery retailers, announced they have entered into a merger agreement to create a truly unique enterprise.

Combination Will Create Strong Local Networks in Attractive Geographies
 

Integrated Platform Will Provide Customers Greater Choice, Convenience, and Access, and Accelerate Omni-Channel Strategy to Reach More Customers and Drive Profitable Growth
 

John Standley to Serve as Chief Executive Officer and Bob Miller to Serve as Chairman of Combined Company

Transaction Expected to Generate Run Rate Cost Synergies of $375 Million and Create Incremental Revenue Opportunities of Over $3.6 Billion

Combined Company Expected to Generate Pro Forma 20181 Revenues of $83 Billion and Adjusted Pro Forma EBITDA of $3.7 Billion (Including Run Rate Cost Synergies)

PRESS RELEASE: EnvisionRx, a pharmacy benefit manager (PBM) and division of EnvisionRxOptions, a wholly owned subsidiary of Rite Aid Corporation, today announced it has achieved renewal of the Drug Therapy Management (DTM) accreditation by URAC. This accreditation recognizes healthcare organizations that provide innovative ways to manage and incorporate DTM into their clinical care management programs. EnvisionRx is one of only four organizations to accomplish this accreditation, which Envision has held since 2007.